Cargando…
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
A series of tumour related markers have been examined in 179 patients receiving primary endocrine therapy for metastatic breast cancer. Significant correlations between therapeutic response (UICC criteria after 6 months of treatment) and appropriate alterations in serum concentrations of carcinoembr...
Autores principales: | Williams, M. R., Turkes, A., Pearson, D., Griffiths, K., Blamey, R. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971340/ https://www.ncbi.nlm.nih.gov/pubmed/2137007 |
Ejemplares similares
-
Objective measurement of therapeutic response in breast cancer using tumour markers.
por: Robertson, J. F., et al.
Publicado: (1991) -
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
por: Williams, M. R., et al.
Publicado: (1986) -
Prognostic factors at the time of diagnosis of metastatic breast cancer.
por: Robertson, J. F., et al.
Publicado: (1998) -
Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?
por: Dixon, A. R., et al.
Publicado: (1993) -
Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer--a comparison with CA15.3.
por: Dixon, A. R., et al.
Publicado: (1993)